Cas:39978-14-8 Methyl 4-aminothiophene-3-carboxylate hydrochloride manufacturer & supplier

Chemical Name:Methyl 4-aminothiophene-3-carboxylate hydrochloride

CAS.NO:39978-14-8

Synonyms:MFCD00068149;methyl 4-aminothiophene-3-carboxylate,hydrochloride;METHYL 3-AMINOTHIOPHENE-4-CARBOXYLATE HYDROCHLORIDE

Molecular Formula:C₆H₈ClNO₂S

Molecular Weight:193.65100

HS Code:2934999090

Physical and Chemical Properties:

Melting point:203-204°C

Boiling point:295.9ºC at 760 mmHg

Density:N/A

Index of Refraction:1.598

PSA:80.56000

Exact Mass:192.99600

LogP:2.50010

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like MFCD00068149 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,METHYL 3-AMINOTHIOPHENE-4-CARBOXYLATE HYDROCHLORIDE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,METHYL 3-AMINOTHIOPHENE-4-CARBOXYLATE HYDROCHLORIDE Use and application,MFCD00068149 technical grade,usp/ep/jp grade.

Related News: However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. Methyl 4-aminothiophene-3-carboxylate hydrochloride manufacturer Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. Methyl 4-aminothiophene-3-carboxylate hydrochloride supplier However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. Methyl 4-aminothiophene-3-carboxylate hydrochloride vendor Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia. Methyl 4-aminothiophene-3-carboxylate hydrochloride factory A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA��s concerns.